Chemotherapy News and Research

Latest Chemotherapy News and Research

New approach delivers drugs to cancer cells while protecting healthy tissues

Cancer treatments, including chemotherapy, have helped many people with the disease to go on to live healthy lives.

26 Aug 2017

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.

24 Aug 2017

New imaging technique reveals oxygen levels in prostate tumors

A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.

24 Aug 2017

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."

23 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

Plant virus-based system can be used to deliver anti-cancer drugs

An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.

21 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Researchers discover synthetic compound effective at relieving neuropathic pain

A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway.

17 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Chapman University’s four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.

16 Aug 2017

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

The most aggressive variant of brain tumor - glioblastoma - has an average survival rate of 15 months. There is therefore an urgent need for new treatment strategies for this group of patients.

16 Aug 2017

Cancer treatment with alternative medicine can double risk of dying: Study finds

A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.

15 Aug 2017

Climbing cost of decades-old drugs threatens to break Medicaid bank

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows.

14 Aug 2017

Alternative medicine use instead of proven cancer therapies results in worse survival

Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.

11 Aug 2017

Colorectal cancer deaths on the rise among Americans: JAMA study

A new study from the American Cancer Society has found that more people living in the United States of America are dying from colon and rectal cancers around the age of 50 years when they are supposed to officially begin screening for these cancers. The new study is published in the JAMA, the Journal of the American Medical Association.

10 Aug 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

New approach delivers drugs to cancer cells while protecting healthy tissues

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

New imaging technique reveals oxygen levels in prostate tumors

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Female patients with esophageal cancer have superior response to treatment, study reveals

Plant virus-based system can be used to deliver anti-cancer drugs

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Sanford Health launches solid tumor oncolytic virus clinical trial

Researchers discover synthetic compound effective at relieving neuropathic pain

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

Cancer treatment with alternative medicine can double risk of dying: Study finds

Climbing cost of decades-old drugs threatens to break Medicaid bank

Alternative medicine use instead of proven cancer therapies results in worse survival

Colorectal cancer deaths on the rise among Americans: JAMA study

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Researchers find racial and gender disparities in survival of patients with anal cancer

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in